Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (175 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Can CAG Growth for IDEXX (IDXX) Stock Return in Q1 Earnings?

by Zacks Equity Research

IDEXX (IDXX) might repeat its gain streak in CAG for Q1, earlier driven by strong double-digit growth in reference labs and consumables plus a high-single-digit rise in rapid assay sales.

    Zacks Equity Research

    LeMaitre Vascular (LMAT) Soars to a 52-Week High, Time to Cash Out?

    by Zacks Equity Research

    LeMaitre Vascular, Inc. is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for LMAT for clues.

      Zacks Equity Research

      Can Higher System Sales Drive Cerner's (CERN) Q1 Earnings?

      by Zacks Equity Research

      Cerner's (CERN) Q1 earnings likely to reflect strength in System Sales and lucrative EHR prospects.

        Zacks Equity Research

        What's in Store for Cardinal Health (CAH) in Q3 Earnings?

        by Zacks Equity Research

        Cardinal Health's (CAH) Pharmaceutical business likely to put up a soft performance in Q3; raised guidance buoys optimism.

          Zacks Equity Research

          Can BD Medical Drive Becton, Dickinson's (BDX) Q2 Earnings?

          by Zacks Equity Research

          Becton, Dickinson (BDX) likely to gain from core BD Medical segment and strategic buyouts.

            Zacks Equity Research

            Can Hologic (HOLX) Diagnostics Growth Recur in Q2 Earnings?

            by Zacks Equity Research

            A strong Panther system and an increasing utilization of Aptima women's health assays add stimulus to Global growth within Hologic's (HOLX) molecular diagnostics.

              Zacks Equity Research

              Here's Why You Should Invest in Stryker (SYK) Right Now

              by Zacks Equity Research

              Stryker (SYK) gains from stellar performance of the flagship Mako platform; guidance solid.

                Zacks Equity Research

                Can Core Unit Drive Pacific Biosciences' (PACB) Q1 Earnings?

                by Zacks Equity Research

                Pacific Biosciences gains ground on solid Sequel Growth, while shrinking service revenues raise concern.

                  Zacks Equity Research

                  Can Diagnostic Revenues Drive PerkinElmer (PKI) Q1 Earnings?

                  by Zacks Equity Research

                  PerkinElmer (PKI) gains from EUROIMMUN buyout, solid guidance buoys optimism.

                    Zacks Equity Research

                    4 MedTech Stocks to Keep in Good Books This Earnings Season

                    by Zacks Equity Research

                    Considering the ageing population, changing market dynamics, upbeat consumer sentiment and increased business investments, the Medical-Device sector appears to be in pink of health.